Building an Industry-Leading Service Organization
As Global Head of Human Pharma Services at Boehringer Ingelheim (2019-2025), Dr. Kurr built the entire go-to-market services organization from a standing start. This included a Global Services Delivery Unit for digital support operations, a Digital Content Factory (offshore production center in India), a Creative Factory launched in 2023, a Global Services Operations Team, and a Global Service Layer Organization with eight colleagues embedded across global markets. The organization expanded tenfold under his leadership and achieved full geographical coverage within four years.
Omnichannel Engagement at Scale
Modern pharma go-to-market requires seamless omnichannel engagement - coordinating field force visits, medical education, digital content, email campaigns, and HCP portals into a single, data-driven experience. Dr. Kurr's partnership with Indegene at Boehringer Ingelheim transformed go-to-market operations and enabled better physician and patient engagement through more agile, data-driven, omnichannel approaches. This is not about adding channels - it is about designing an operating model that orchestrates them effectively.
Content Factory and Creative Services
Pharma content production is uniquely complex - subject to medical, legal, and regulatory (MLR) review, localization requirements across dozens of markets, and brand consistency standards. Dr. Kurr designed and launched both a Digital Content Factory and a Creative Factory, creating a production system that delivers content at scale while maintaining quality and compliance. The content factory model reduces production timelines, lowers per-asset costs, and creates the operational infrastructure needed for personalized, omnichannel content at scale.
Medical Affairs and Market Access
Commercial transformation in pharma cannot ignore medical affairs and market access - both are increasingly central to commercial success. Dr. Kurr's approach integrates medical affairs services optimization (including medical information, medical education, and publication support) with commercial operations to create a unified go-to-market model. Market access and value management are addressed as part of the operating model, not as separate functions competing for resources.